Quantinno Capital Management LP Novo Cure LTD Transaction History
Quantinno Capital Management LP
- $15 Billion
- Q1 2025
A detailed history of Quantinno Capital Management LP transactions in Novo Cure LTD stock. As of the latest transaction made, Quantinno Capital Management LP holds 988,252 shares of NVCR stock, worth $17.7 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
988,252
Previous 294,639
235.41%
Holding current value
$17.7 Million
Previous $8.78 Million
100.57%
% of portfolio
0.12%
Previous 0.09%
Shares
11 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$217 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$202 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$160 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$98.9 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$93.4 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...